ARCA:IHE

iShares U.S. Pharmaceuticals ETF

$ 68.75 0.41 ( +0.6%) 03:59 PM EST
PE Ratio:
19.24
PB Ratio:
3.19
Volume:
22.76K
Dividend Yield %:
2.6
Last Holding update 2024-08-26 36 Stocks (3 new)
Value $683.00 Mil Turnover 9 %
Top Holdings: LLY(23.56%) JNJ(22.69%) PFE(4.57%) VTRS(4.51%) ZTS(4.45%)
Portfolio Report
Registrant: iSHARES TRUST
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Key Statistics

Name Value
Day's Open ($) 68.15
Day's Range ($) 67.92 - 68.75
Day's Volume 22,763
52-Week Range ($) 56.03 - 72.94
Beta 0.58
Volatility 13.78
14-Day RSI 31.76
14-Day ATR ($) 0.692435
20-Day SMA ($) 70.452

Fundamental Data

Name Value
Market Cap (Mil $) 622.225
Shares Outstanding (Mil) 9.05
PE Ratio 19.24
PE Ratio (10y Range) 9.54 - 29.8
PE Ratio (10y Median) 21.16
PB Ratio 3.19
PB Ratio (10y Range) 2.53 - 3.99
PB Ratio (10y Median) 2.97

Dividend Data

Name Value
Dividends per Share (TTM) ($) 1.787
Dividend Yield % 2.6
Dividend Yield % (10y Range) 0.84 - 3.83
Dividend Yield % (10y Median) 1.37
Next Dividend Payment Date
Dividend Frequency Quarterly

IHE iShares U.S. Pharmaceuticals ETF Fundamental Charts

Historical TTM Price-to-Earnings for IHE iShares U.S. Pharmaceuticals ETF

Historical TTM Price-to-Earnings without NRI for IHE iShares U.S. Pharmaceuticals ETF

Historical Price-to-Book Ratio for IHE iShares U.S. Pharmaceuticals ETF

Historical Dividend Yields for IHE iShares U.S. Pharmaceuticals ETF

IHE iShares U.S. Pharmaceuticals ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:IHE

No Available Data

ARCA:IHE is held by these investors

No Available Data
iShares U.S. Pharmaceuticals E... Top Holdings of 2024-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
LLY 		Eli Lilly and Co
177,785
160962.980
-5.96%
23.560
-1.35%
0.020
+4.12%
+38.95%
765205.408
Drug Manufacturers
JNJ 		Johnson & Johnson
1,060,380
154985.140
+14.61%
22.690
+2.89%
0.040
-1.05%
+3.40%
381247.098
Drug Manufacturers
PFE 		Pfizer Inc
1,114,953
31196.380
+2.83%
4.570
+0.13%
0.020
-5.88%
+1.59%
158619.051
Drug Manufacturers
VTRS 		Viatris Inc
2,900,916
30836.740
+20.04%
4.510
+0.75%
0.240
+1.47%
+10.60%
13857.614
Drug Manufacturers
ZTS 		Zoetis Inc
175,368
30401.800
+9.17%
4.450
+0.37%
0.040
+0.49%
-10.32%
79075.691
Drug Manufacturers
BMY 		Bristol-Myers Squibb Co
727,143
30198.250
+31.66%
4.420
+1.06%
0.040
+18.88%
+14.56%
113476.485
Drug Manufacturers
MRK 		Merck & Co Inc
236,862
29323.520
-0.58%
4.290
-0.03%
0.010
-8.89%
-4.98%
257663.367
Drug Manufacturers
RPRX 		Royalty Pharma PLC
1,086,489
28650.710
+9.60%
4.190
+0.37%
0.240
+1.07%
+0.26%
12341.543
Biotechnology
CTLT 		Catalent Inc
507,000
28508.610
+8.32%
4.170
+0.32%
0.280
-1.13%
+30.16%
10614.798
Drug Manufacturers
ELAN 		Elanco Animal Health Inc
1,384,402
19976.920
+8.48%
2.920
+0.23%
0.280
+6.92%
-14.97%
6263.099
Drug Manufacturers

iShares U.S. Pharmaceuticals ETF's Historical Top Holdings Breakdowns

iShares U.S. Pharmaceuticals ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
JNJ 		Johnson & Johnson2024-06-30Add
+2.89%
●
144.38 ($148.72) 157.78
$158.35
6.48%
Add 14.61%
1,060,380
135,211
LLY 		Eli Lilly and Co2024-06-30Reduce
-1.35%
●
724.87 ($799.92) 909.04
$806.06
0.77%
Reduce -5.96%
177,785
-11,266
BMY 		Bristol-Myers Squibb Co2024-06-30Add
+1.06%
●
40.25 ($44.75) 52.99
$55.95
25.03%
Add 31.66%
727,143
174,849
VTRS 		Viatris Inc2024-06-30Add
+0.75%
●
10.05 ($11.05) 12.02
$11.61
5.07%
Add 20.04%
2,900,916
484,273
ITCI 		Intra-Cellular Therapies Inc2024-06-30Add
+0.43%
●
64.76 ($69.36) 79.84
$89.24
28.66%
Add 18.67%
275,053
43,283
ZTS 		Zoetis Inc2024-06-30Add
+0.37%
●
145.54 ($166.41) 178.83
$175.27
5.32%
Add 9.17%
175,368
14,734
RPRX 		Royalty Pharma PLC2024-06-30Add
+0.37%
●
26.26 ($27.72) 29.9
$27.54
-0.65%
Add 9.6%
1,086,489
95,186
CTLT 		Catalent Inc2024-06-30Add
+0.32%
●
53.58 ($55.79) 57.02
$58.48
4.82%
Add 8.32%
507,000
38,930
ELVN 		Enliven Therapeutics Inc2024-06-30New Buy
+0.24%
●
16.78 ($21.05) 24.7
$28.01
33.06%
New holding
69,154
69,154
ELAN 		Elanco Animal Health Inc2024-06-30Add
+0.23%
●
12.93 ($15.98) 18.45
$12.67
-20.71%
Add 8.48%
1,384,402
108,197

iShares U.S. Pharmaceuticals ETF Total Holding History ($B)

To

iShares U.S. Pharmaceuticals ETF's Asset Allocation

To

iShares U.S. Pharmaceuticals ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

iShares U.S. Pharmaceuticals ETF's Hypothetical Growth since 2024-06-30

iShares U.S. Pharmaceuticals ETF's Yearly Returns

Year Portfolio % % Excess Gain %

iShares U.S. Pharmaceuticals ETF's Holdings Heat Map

Size field:

iShares U.S. Pharmaceuticals ETF's Holdings Bubble Chart

iShares U.S. Pharmaceuticals ETF News

  • 1

Discussions on iShares U.S. Pharmaceuticals ETF

User's Avatar
How would you rate this stock? IHE
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.